Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma

Although standard chemotherapy for esophageal cancer patients is fluorouracil and cisplatin, the prognosis is still unsatisfactory. A new therapeutic regimen combining docetaxel, cisplatin, and 5‐fluorouracil was recently developed to improve both local and distant tumor control. We developed a new...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yoshihiro, Yoshida, Kazuhiro, Tanahashi, Toshiyuki, Okumura, Naoki, Matsuhashi, Nobuhisa, Yamaguchi, Kazuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968606/
https://www.ncbi.nlm.nih.gov/pubmed/27061001
http://dx.doi.org/10.1111/cas.12943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968606/
https://www.ncbi.nlm.nih.gov/pubmed/27061001
http://dx.doi.org/10.1111/cas.12943

Ejemplares similares